84 related articles for article (PubMed ID: 18172658)
1. Retinoblastoma gene abnormalities in early laryngeal cancer.
Rafferty M; Walker C; Husband D; Helliwell T; Fenton J; Jones A
Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S83-7. PubMed ID: 18172658
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity for Rb locus and pRb immunostaining in laryngeal cancer: a clinicopathologic, molecular and immunohistochemical study.
Pietruszewska W; Klatka J; Borzecki A; Rieske P
Folia Histochem Cytobiol; 2008; 46(4):479-85. PubMed ID: 19141402
[TBL] [Abstract][Full Text] [Related]
3. LOH detected by microsatellite markers reveals the clonal origin of recurrent laryngeal squamous cell carcinoma.
Cui Z; Pan X; Wang Q
PLoS One; 2014; 9(11):e111857. PubMed ID: 25365429
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities and the implication of retinoblastoma locus and its protein product in head and neck cancers.
Yokoyama J; Shiga K; Sasano H; Suzuki M; Takasaka T
Anticancer Res; 1996; 16(2):641-4. PubMed ID: 8687109
[TBL] [Abstract][Full Text] [Related]
6. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
7. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
Xu XF; Gao YN; Cheng SJ
Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.
Semczuk A; Marzec B; Roessner A; Jakowicki JA; Wojcierowski J; Schneider-Stock R
Virchows Arch; 2002 Dec; 441(6):577-83. PubMed ID: 12461615
[TBL] [Abstract][Full Text] [Related]
9. The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.
Starska K; Forma E; Nowacka-Zawisza M; Lewy-Trenda I; Ciesielski P; Pietruszewska W; Skóra M; Bryś M
Tumour Biol; 2016 Apr; 37(4):4541-57. PubMed ID: 26503213
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity of tumor suppressor genes (p16, Rb, E-cadherin, p53) in hypopharynx squamous cell carcinoma.
Sang-Hyuk Lee SH; Lee NH; Jin SM; Rho YS; Jo SJ
Otolaryngol Head Neck Surg; 2011 Jul; 145(1):64-70. PubMed ID: 21493295
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity of APC and CDH1 genes in laryngeal squamous cell carcinoma.
Pećina-Slaus N; Kljaić M; Nikuseva-Martić T
Pathol Res Pract; 2005; 201(8-9):557-63. PubMed ID: 16259108
[TBL] [Abstract][Full Text] [Related]
12. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma.
Yoo GH; Xu HJ; Brennan JA; Westra W; Hruban RH; Koch W; Benedict WF; Sidransky D
Cancer Res; 1994 Sep; 54(17):4603-6. PubMed ID: 8062250
[TBL] [Abstract][Full Text] [Related]
13. Postoperative radiotherapy for laryngeal carcinoma: the prognostic role of subcellular Maspin expression.
Lionello M; Blandamura S; Staffieri C; Tealdo G; Giacomelli L; Marchese Ragona R; de Filippis C; Staffieri A; Marioni G
Am J Otolaryngol; 2015; 36(2):184-9. PubMed ID: 25459315
[TBL] [Abstract][Full Text] [Related]
14. [Microsatellite instability and loss of heterozygosity of fragile histidine triad gene in laryngeal squamous cell carcinoma].
Yin DT; Dong MM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Jan; 40(1):45-8. PubMed ID: 15906520
[TBL] [Abstract][Full Text] [Related]
15. [Epidermoid carcinoma of the cervix uteri: molecular abnormalities of p53 and rb genes].
Wistuba I; Capurro I
Rev Med Chil; 1996 May; 124(5):553-60. PubMed ID: 9035506
[TBL] [Abstract][Full Text] [Related]
16. [Study of RB gene in carcinoma of larynx].
Wang B; Chen Y; Wen S; Wang J; Huangpu H; Li Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 17(2):89-91. PubMed ID: 12833691
[TBL] [Abstract][Full Text] [Related]
17. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
Jones AS; Fish B; Fenton JE; Husband DJ
Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of microsatellite instability in laryngeal squamous cell carcinoma].
García Martínez J; Pérez-Escuredo J; García-Carracedo D; Alonso-Guervós M; Suárez-Nieto C; Llorente-Pendás JL; Alvarez-Marcos C; Hermsen M
Acta Otorrinolaringol Esp; 2012; 63(2):79-84. PubMed ID: 22100049
[TBL] [Abstract][Full Text] [Related]
19. Protein expression of p53 and Bcl-2 has a strong correlation with radiation resistance of laryngeal squamous cell carcinoma but does not predict the radiation failure before treatment.
Ogawa T; Shiga K; Tateda M; Saijo S; Suzuki T; Sasano H; Miyagi T; Kobayashi T
Oncol Rep; 2003; 10(5):1461-6. PubMed ID: 12883724
[TBL] [Abstract][Full Text] [Related]
20. p16MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx.
Jares P; Fernández PL; Nadal A; Cazorla M; Hernández L; Pinyol M; Hernández S; Traserra J; Cardesa A; Campo E
Oncogene; 1997 Sep; 15(12):1445-53. PubMed ID: 9333020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
